FutureDx Summit 2026 · For Nordic Diagnostics Companies
You Already Know How to Sell to a Public Payer
Nordic diagnostics firms sell into public, evidence-driven health systems every day. FutureDx Summit 2026 is the Nordic diagnostics conference that opens a far bigger one: meet 150 plus validated NHS buyers in London, in two days.
P.S. Validate demand with real buyers first. Build the UK operation second.
Instant download. Your PDF opens as soon as you submit.
The opportunity
Why the UK, Why Now
For a Nordic diagnostics company, the UK is the rare export market that is large, close, and works the way you already know.
A Public Payer You Recognise
Like Nordic health systems, the NHS is a public single-payer buyer, only far larger.
A Familiar Buying Logic
Evidence, value, and outcomes drive the decision, as they do at home.
English Comes Naturally
Among the most English-fluent regions in the world, so no barrier.
The First Dedicated Summit
FutureDx is the UK’s inaugural infectious-disease and molecular diagnostics event, so you arrive early.
The smart sequence
Test the Market Before You Build the Office
Most companies enter a country the expensive way, then find out if it was worth it. There is a cheaper order of operations.
Build First, Learn Later
- Commission market research
- Hire a UK sales lead
- Appoint distributors
- Fund a UK office
- Wait quarters to learn if it works
Learn First, Build With Evidence
- Tell us the buyers you want to reach
- Meet validated NHS buyers across two days
- Hear real demand first-hand
- Build relationships before you spend big
- Decide where to invest with evidence
The familiar buyer
The NHS Is a Buyer You Already Understand
From Denmark to Finland, Nordic companies are used to selling into public, evidence-led, value-focused health systems. The NHS runs on the same logic at far greater scale, so the selling motion is familiar even though the market is bigger. A focused summit removes the hardest part: getting in front of the right senior buyers.
What Makes the Crossing Easy
- A public single-payer buyer, like home
- Evidence-and-value decisions you know
- Near-native English, no localisation
- A short flight, same business day
- UKCA and CE regulatory ground
- Start with meetings, not a UK office
The room
The Buyers You Came to Meet
Market entry only works if you reach the people who decide. Here is who is in the room.
Delegate Seniority
A Whole Market, in One Trip
Rather than a string of flights to meet trusts one at a time, you meet senior, validated buyers from across the UK in two days. For market entry, that is the lowest-friction way to find out if the UK is for you. Reach them through the 1:1 meetings programme or a sponsorship package.
The brief
The UK Entry Brief
Everything to Plan a UK Market Test
- The audience profile and NHS buyer mix
- Which package fits a market-entry plan
- How the pre-arranged meeting model works
- A high-level note on UK regulation and entry
- Pricing and what is included
Instant download. Your PDF opens as soon as you submit.
Questions
What a Nordic Company Asks
Why should a Nordic diagnostics company look at the UK?
The NHS is a public, single-payer health system much like the ones you already sell to at home, only far larger. It is a short flight away and business is done in English. FutureDx lets you meet 150 plus validated NHS buyers in two days, an efficient way to test demand before committing to a UK operation.
We are based in Denmark, Sweden, Norway, or Finland. Is this for us?
Yes. FutureDx is relevant across the Nordic region, from Medicon Valley to the wider Scandinavian and Finnish life-science clusters. Tell the team your country and products and meetings are matched to the UK buyers that fit.
We do not have a UK office yet. Can we still take part?
Yes, and that is the point. You can begin with pre-arranged meetings rather than infrastructure, hear demand first-hand, and then decide where to invest. A focused summit is a low-commitment way to validate the UK before you hire or appoint distributors.
What about regulation, UKCA, and CE?
The UK operates its own UKCA marking alongside continued recognition of CE marking for many medical devices, and the position has shifted in recent years. The entry brief covers it at a high level and we can point you to the right advisers. We do not provide regulatory advice ourselves.
Who will we meet?
Senior diagnostics professionals from across the UK, more than 60% at VP level and above, every one validated as a decision-maker or procurement influencer before they register. You can tell the team which trusts, regions, and roles you most want to reach.
How many meetings can we get?
It depends on your package: pre-arranged meetings range from 6 with Gold to 15 with Headline, or up to 20 with the standalone 1:1 Meetings programme. Each is a confirmed conversation with a validated NHS buyer. See the 1:1 meetings programme.
When and where is FutureDx Summit 2026 held?
FutureDx Summit 2026 runs across two days on 27 and 28 October 2026 in London, UK, with a drinks reception on Day 1.
Head south
Test the UK Market in Two Days
Send your details and a senior member of the team replies with the UK entry brief and builds a plan around the buyers and regions you most want to reach.
- Validated NHS buyers, no UK office required
- Pre-arranged meetings across two days
- A reply from a person, not an autoresponder
P.S. Looking from elsewhere in Europe? See Germany companies or Netherlands companies.